newsfilter
← Latest News
GlobeNewswire·

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

NESS ZIONA, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic